From All Angles: Minimizing CMV in High-Risk Kidney Transplant Recipients

Goal Statement
The goal of this activity is to improve learners’ knowledge and competence for individualizing CMV prevention to optimize outcomes in kidney transplant recipients.

Target Audience
This activity is intended for transplant and infectious diseases specialists, including physicians, nurses, pharmacists, and other healthcare professionals, who care for patients at risk for CMV following kidney transplantation.

Learning Objectives
Upon completion of this activity, participants should be able to:

• Update antiviral protocols and clinical pathways for CMV prevention in high-risk kidney transplant recipients based on the latest developments and clinical data

• Design antiviral regimens for kidney transplant recipients at high risk for CMV disease to mitigate the impact of CMV replication on patient outcomes

• Select antivirals for CMV prophylaxis in kidney transplant recipients to minimize the impact of antiviral toxicities on transplant clinical courses